Researchers demonstrate activity of mebendazole in metastatic melanoma

User rating: 4.5 / 5 after 2 vote(s)

Mebendazoles mechanism of action in melanoma. Credit: NYU Langone Medical Center
Mebendazole's mechanism of action in melanoma. Credit: NYU Langone Medical Center
Click here to enlarge image

Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.


Full story »
All News summaries from Medicine & Health news
All News summaries for August 07, 2008
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive